Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Clin Transl Oncol ; 20(11): 1439-1447, 2018 Nov.
Article de Anglais | MEDLINE | ID: mdl-29704232

RÉSUMÉ

BACKGROUND: Ependymoma is the third most common pediatric brain tumor and occurs most frequently in the posterior fossa. However, the lack of immortalized cell lines, xenografts, or animal models has significantly hindered the study of pediatric posterior fossa ependymoma (P-PF-EPN) pathogenesis. This prompted us to use clinical big data to study this rare disease. METHODS: Application of the robust rank aggregation method revealed CD44 as a reliable biomarker in P-PF-EPN. 120 P-PF-EPN samples after surgical resection were selected for Kaplan-Merier and Cox proportion hazard regression survival analysis. Immunohistochemical analysis was performed to assess CD44 expression in the tumor samples. The miRNA profile was determined using a whole-genome miRNA microarray. The expression patterns of related mRNAs, miRNAs and proteins were validated by qRT-PCR or Western blotting. RESULTS: CD44 was found to be an independent predictor of prognosis in survival analysis. It improved the accuracy of using LAMA2/NELL2 for classifying P-PF-EPN molecular subgroups. Fourteen miRNAs were underexpressed, and one miRNA was overexpressed in CD44-positive P-PF-EPNs. miR-543, miR-495-3p, miR-299-3p, miR-139-5p and miR-128-3p were identified to have CD44 positively co-regulated potential target oncogenes. Two PI3K-Akt signaling pathway related potential target oncogenes (VEGFA, CSF1) for miR-299-3p and miR-495-3p were validated overexpression in CD44 positive P-PF-EPNs. Abnormal activation of the PI3K-Akt pathway was confirmed in CD44-positive cases. CONCLUSIONS: CD44 is of great clinical significance as a prognostic biomarker. The survival difference between CD44 positive and negative P-PF-EPN is determined by a complex functional miRNA-mRNA-signaling pathway regulatory network.


Sujet(s)
Épendymome/diagnostic , Épendymome/génétique , Antigènes CD44/génétique , Tumeurs sous-tentorielles/diagnostic , Tumeurs sous-tentorielles/génétique , microARN/génétique , Adolescent , Marqueurs biologiques tumoraux/génétique , Marqueurs biologiques tumoraux/métabolisme , Enfant , Enfant d'âge préscolaire , Épendymome/mortalité , Épendymome/anatomopathologie , Femelle , Analyse de profil d'expression de gènes , Régulation de l'expression des gènes tumoraux , Humains , Antigènes CD44/métabolisme , Tumeurs sous-tentorielles/mortalité , Tumeurs sous-tentorielles/anatomopathologie , Mâle , Analyse sur microréseau , Pronostic , Analyse de survie
2.
Neurosurg Rev ; 31(4): 421-30; discussion 430, 2008 Oct.
Article de Anglais | MEDLINE | ID: mdl-18521636

RÉSUMÉ

Tentorial meningiomas comprise 3-5% of the intracranial meningiomas. Different locations and sinus invasion require special surgical skills. This study aimed to analyze factors influencing the outcome of 29 patients (30 tumors) with tentorial meningiomas surgically treated. The study included 22 female and seven male patients, with age of 18-76 years old, and a follow-up of 6-179 months. Eight tumors were located on the inner tentorial ring, 15 on the outer ring, four were falcotentorial, and three attached/invading the torcula. Outcome was analyzed using survival and recurrence-free survival (RFS) curves. Twenty-seven tumors were WHO grade I and three were grades II-III. Total and subtotal resections were reached in 87.5% and 12.5% of tumors. Survival was better for patients with grade I tumors and similar according to sex, location, size, and extent of resection. Recurrence/regrowing rate was 12.5%. RFS curves were better for patients with grade I or with radical resection and similar according to sex, location, and size. There was no operative mortality. Permanent postoperative cranial nerve deficits occurred in 9.7% (all inner ring tumors). Despite being many times large-sized, surgical treatment of tentorial meningiomas gives good results. Prognostic factors for recurrence were histopathologic grade III and subtotal resection. Radical resection allowed better results. Nevertheless, subtotal resection may be acceptable for cases with cranial nerves or sinuses invasions.


Sujet(s)
Dure-mère , Tumeurs sous-tentorielles/chirurgie , Tumeurs des méninges/chirurgie , Méningiome/chirurgie , Tumeurs sus-tentorielles/chirurgie , Adolescent , Adulte , Sujet âgé , Femelle , Études de suivi , Humains , Tumeurs sous-tentorielles/mortalité , Tumeurs sous-tentorielles/anatomopathologie , Mâle , Tumeurs des méninges/mortalité , Tumeurs des méninges/anatomopathologie , Méningiome/mortalité , Méningiome/anatomopathologie , Adulte d'âge moyen , Études rétrospectives , Tumeurs sus-tentorielles/mortalité , Tumeurs sus-tentorielles/anatomopathologie , Taux de survie , Résultat thérapeutique , Jeune adulte
3.
Childs Nerv Syst ; 24(3): 307-12, 2008 Mar.
Article de Anglais | MEDLINE | ID: mdl-17876589

RÉSUMÉ

OBJECTIVE: The purpose of this study is to present our experience with ten cases of Central nervous system atypical teratoid rhabdoid tumor (CNS/ATRT). PATIENTS AND METHODS: A series of ten patients with CNS/ATRT, were diagnosed and treated between 1990 and 2005, at the National Institute of Pediatrics, in Mexico City. The gender, age of presentation, clinical features, tumor localization, imaging studies, grade of tumor resection, complications, adjuvant therapy, and survival are presented. RESULTS: The mean age at diagnosis was 37.8 months, seven cases were male, and their average clinical course was 1.3 months. The more common clinical presentation was intracranial hypertension with cranial nerve deficits; location was infratentorial in four patients and supratentorial in six. Hydrocephalus was present as the most common complication (seven cases). In nine patients, the grade of resection was total or subtotal. In one case, it was only possible to perform a biopsy. There were two cases with longer survival (9 and 16 months), and their tumors were resected in total or subtotal manner and received adjuvant therapy (radiotherapy and chemotherapy). CONCLUSIONS: Preliminary results, show that in older children, we can improve their survival with the subtotal or total resection of the tumor and the addition of chemotherapy and radiotherapy.


Sujet(s)
Tumeurs du système nerveux central/anatomopathologie , Tumeurs sous-tentorielles/anatomopathologie , Tumeur rhabdoïde/anatomopathologie , Tumeurs sus-tentorielles/anatomopathologie , Tératome/anatomopathologie , Tumeurs du système nerveux central/classification , Tumeurs du système nerveux central/mortalité , Tumeurs du système nerveux central/thérapie , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Hydrocéphalie/étiologie , Hydrocéphalie/anatomopathologie , Nourrisson , Tumeurs sous-tentorielles/classification , Tumeurs sous-tentorielles/mortalité , Tumeurs sous-tentorielles/thérapie , Mâle , Études rétrospectives , Tumeur rhabdoïde/mortalité , Tumeur rhabdoïde/thérapie , Tumeurs sus-tentorielles/classification , Tumeurs sus-tentorielles/mortalité , Tumeurs sus-tentorielles/thérapie , Analyse de survie , Tératome/mortalité , Tératome/thérapie , Résultat thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE